In the suit, which was filed in Franklin County Circuit Court in Frankfort, the company is accused of hiding the risks associated with the drug and its effectiveness on patients.
According to the suit, GlaxoSmithKline violated the state's Consumer Protection Act because the drug claims to offer a reduction in cardiovascular risks by those with diabetes, while the suit asserts it actually hurts people by increasing the cardiovascular risks.
Kentucky is looking for an injunction against the company and civil penalties up to $10,000 for each infraction.
GlaxoSmithKline via spokesman Kevin Colgan responded to the suit, saying the company did nothing wrong when studying and marketing Avandia.
No comments:
Post a Comment